O03 High-dose riboflavin therapy in Brown-Vialetto-Van Laere syndrome: clinical and biochemical improvement

Abstract

O03 High-dose riboflavin therapy in Brown-Vialetto-Van Laere syndrome: clinical and biochemical improvement A.R. Foley, A.A. Broomfield, A. Pandraud, J.O. Johnson, A.B. Singleton, I.P. Hargreaves, J.M. Land, S. Grunewald, S. Rahman, P. Clayton, H. Houlden, M.M. Reilly, F. Muntoni. Dubowitz Neuromuscular Centre, Great Ormond Street Hospital for Children and UCL Institute of Child Health, London, UK; Department of Clinical and Molecular Genetics, UCL Institute of Child Health, London, UK; MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London WC1N 3BG, UK; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA; Neurometabolic Unit, National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, London, UK; Metabolic Medicine Unit, Great Ormond Street Hospital for Children and UCL Institute of Child Health, London, UK